Novo Nordisk(CH:NOV)
CHF 173.420.00 (0.00%)
CH:NOV
Novo Nordisk ownership
CHF 173.42
At close:0.00 (0.00%)
Novo Nordisk (NOV) Ownership - Who Owns Novo Nordisk?
24 Followers
Novo Nordisk (NOV) Ownership Overview
- 0.01% Insiders
- 12.15% Mutual Funds
- <0.01% Other Institutional Investors
- 12.76% ETFs
- 75.07% Public Companies and Individual Investors
The ownership structure of Novo Nordisk (CH:NOV) stock is a mix of institutional, retail, and individual investors. Approximately 24.92% of the company’s stock is owned by Institutional Investors, 0.01% is owned by Insiders, and 75.07% is owned by Public Companies and Individual Investors.
The ownership structure of Novo Nordisk (CH:NOV) stock is a mix of institutional, retail, and individual investors. Approximately 24.92% of the company’s stock is owned by Institutional Investors, 0.01% is owned by Insiders, and 75.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Feb 10, 2026 | Karsten Munk Knudsen | kr 8,381,421 | |
| Feb 09, 2026 | Martin Holst Lange | kr 7,035,600 | |
| Feb 04, 2026 | David Moore | kr 2,085,808 | |
| Feb 04, 2026 | Emil Kongshøj Larsen | kr 1,110,704 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 122,936,874 | Institution | 3.63% | 25,616,110,562 |
| Ishares | 119,932,053 | Institution | 3.54% | 24,990,002,020 |
| Amundi | 65,226,016 | Institution | 1.92% | 13,591,014,502 |
| Vanguard Star Funds | 46,882,417 | Institution | 1.38% | 9,768,795,465 |
| Europacific Growth Fund | 39,274,283 | Institution | 1.16% | 8,183,503,800 |
| Eupac Fund | 36,203,561 | Institution | 1.07% | 7,543,663,598 |
| Xtrackers | 32,868,648 | Institution | 0.97% | 6,848,774,446 |
| Vanguard Tax-managed Funds | 31,126,371 | Institution | 0.92% | 6,485,739,673 |
| Capital World Growth & Income Fund | 26,018,958 | Institution | 0.77% | 5,421,518,241 |
| Fidelity Salem Street Trust | 20,212,714 | Institution | 0.60% | 4,211,682,791 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 46,882,417 | Institution | 1.38% | 9,768,795,465 |
| Europacific Growth Fund | 39,274,283 | Institution | 1.16% | 8,183,503,800 |
| Eupac Fund | 36,203,561 | Institution | 1.07% | 7,543,663,598 |
| Vanguard Tax-managed Funds | 31,126,371 | Institution | 0.92% | 6,485,739,673 |
| Capital World Growth & Income Fund | 26,018,958 | Institution | 0.77% | 5,421,518,241 |
| Fidelity Salem Street Trust | 20,212,714 | Institution | 0.60% | 4,211,682,791 |
| Tiaa-cref Funds | 18,679,875 | Institution | 0.55% | 3,892,288,194 |
| Vanguard International Equity Index Funds | 17,905,136 | Institution | 0.53% | 3,730,857,378 |
| Income Fund Of America | 15,679,502 | Institution | 0.46% | 3,267,106,473 |
| Dodge & Cox Funds | 14,713,200 | Institution | 0.43% | 3,065,760,058 |
FAQ
Who Owns Novo Nordisk (CH:NOV)?
According to the latest TipRanks data, approximately 24.92% of the company's stock is held by institutional investors, 0.01% is held by insiders, and 75.07% is held by public companies and individual investors.
What percentage of Novo Nordisk (CH:NOV) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.92% of Novo Nordisk (CH:NOV) stock is held by institutional investors: 12.15% by mutual funds, 12.76% by ETFs and <0.01% by other institutional investors.
What percentage of Novo Nordisk (CH:NOV) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.07% of Novo Nordisk (CH:NOV) stock is held by public companies and individual investors.
Who owns the most shares of Novo Nordisk (CH:NOV)?
Vanguard owns the most shares of Novo Nordisk (CH:NOV).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
